A carregar...
Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).
The thioether phospholipid ilmofosine (BM 41 440) is a new anti-cancer drug presently undergoing phase II clinical trials. Because resistance to anti-tumour drugs is a major problem in cancer treatment, we investigated the resistance of different cell lines to this compound. Here we report that the...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
1997
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2228059/ https://ncbi.nlm.nih.gov/pubmed/9328144 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|